Translated: Guidance on Covid-19 antiviral treatment Molnupiravir

The UK Health Security Agency have created a leaflet for those who have been prescribed Molnupiravir including how long to take the medicines for, what to do if you are pregnant or breastfeeding, and how to report side effects.

This is part of the NHS offer of new antibody and antiviral treatments to people with Covid-19 who are at highest risk of becoming seriously ill.

Paper copies of this leaflet are available free to order or download in the following languages:

AlbanianArabicBengaliBulgarianChinese (simplified)Chinese (traditional, Cantonese)EstonianFarsiFrenchGreekGujaratiHindiLatvianLithuanianPanjabiPashtoPolishPortugueseRomanianRomanyRussianSomaliSpanishTagalogTurkish, TwiUkrainianUrdu and Yiddish.

An English large print and Braille version of this leaflet are available to order.

An audio version of this leaflet is available to download.

A BSL video of the leaflet is available to view.

BSL video of the guidance on Covid-19 antiviral treatment Molnupiravir.